1.
Ann N Y Acad Sci
; 1054: 495-9, 2005.
Article
in English
| MEDLINE
| ID: mdl-16339705
ABSTRACT
Extended antigen (C, E, K) matching decreased the incidence of alloantibody (alloAB) and autoantibody (autoAB) formation, in addition to eliminating transfusion reactions in the multiply transfused sickle cell disease patients. AlloAB formation possibly transforms the immune system into a hyperactive state leading to further and earlier alloAB and autoAB formation. However, additional CEK matching results in marked overuse of Rh-negative packed red blood cell (pRBC) units, 30 minutes' extra time of a skilled technologist, and 153 dollars extra CEK reagent cost per unit to find CEK-matched pRBCs for every transfusion for these multiply transfused patients.
Subject(s)
Anemia, Sickle Cell/immunology , Autoantibodies/blood , Blood Group Antigens/immunology , Erythrocyte Transfusion/adverse effects , Immunization , Isoantibodies/blood , Adolescent , Adult , Aged , Anemia, Sickle Cell/blood , Anemia, Sickle Cell/therapy , Blood Group Incompatibility/immunology , Blood Grouping and Crossmatching , Child , Child, Preschool , Female , Humans , Incidence , Infant , Male , Middle Aged , Retrospective Studies
2.
Am J Clin Pathol
; 116(5): 778-80, 2001 Nov.
Article
in English
| MEDLINE
| ID: mdl-11710697
Subject(s)
Blood Component Transfusion , Leukapheresis , Leukocytes , Blood Component Transfusion/economics , Blood Component Transfusion/methods , Blood Component Transfusion/trends , Consumer Product Safety/standards , Humans , Leukapheresis/economics , Leukapheresis/methods , Leukapheresis/trends
3.
Am J Clin Pathol
; 116(5): 781-2, 2001 Nov.
Article
in English
| MEDLINE
| ID: mdl-11710698
Subject(s)
Cell Transformation, Neoplastic , Leukemia, B-Cell/pathology , Leukemia, Prolymphocytic/pathology , Lymphoma, Mantle-Cell/pathology , Antigens, CD/metabolism , Biomarkers, Tumor/metabolism , Bone Marrow/pathology , Cladribine/therapeutic use , DNA, Neoplasm/analysis , Humans , Immunophenotyping , In Situ Hybridization, Fluorescence , Leukemia, B-Cell/drug therapy , Leukemia, B-Cell/genetics , Leukemia, B-Cell/metabolism , Leukemia, Prolymphocytic/drug therapy , Leukemia, Prolymphocytic/genetics , Leukemia, Prolymphocytic/metabolism , Lymphoma, Mantle-Cell/drug therapy , Lymphoma, Mantle-Cell/genetics , Lymphoma, Mantle-Cell/metabolism , Male , Middle Aged
4.
CAP Today
; 15(1): 6, 8, 2001 Jan.
Article
in English
| MEDLINE
| ID: mdl-11317558
5.
Am J Clin Pathol
; 113(5): 743-5, 2000 May.
Article
in English
| MEDLINE
| ID: mdl-10800410
6.
Am J Surg Pathol
; 24(2): 306-7, 2000 Feb.
Article
in English
| MEDLINE
| ID: mdl-10680900
Subject(s)
Hemangioma/pathology , Splenic Neoplasms/pathology , Biomarkers, Tumor/analysis , Hemangioma/chemistry , Hemangioma/complications , Hemangioma/surgery , Humans , Immunohistochemistry , Middle Aged , Neoplasms, Multiple Primary/chemistry , Neoplasms, Multiple Primary/pathology , Neuroendocrine Tumors/complications , Neuroendocrine Tumors/pathology , Pancreatic Neoplasms/complications , Pancreatic Neoplasms/pathology , Splenic Neoplasms/chemistry , Splenic Neoplasms/complications , Splenic Neoplasms/surgery
7.
QRC Advis
; 15(2): 1-3, 1998 Dec.
Article
in English
| MEDLINE
| ID: mdl-10338974
8.
J La State Med Soc
; 144(3): 95-8, 1992 Mar.
Article
in English
| MEDLINE
| ID: mdl-1506765
